Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Terminated 2Completed 1

Sponsor Class

NIH 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3Thoracic 2Gastrointestinal 2Lymphoid 1Dermatologic 1

Conditions

Breast Neoplasms 17Lymphoma 16Multiple Myeloma 13Neoplasm Metastasis 10Leukemia, Myeloid, Acute 10Melanoma 9Lung Neoplasms 9Prostatic Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Squamous Cell Carcinoma of Head and Neck 6Lymphoma, Non-Hodgkin 6Triple Negative Breast Neoplasms 5Pancreatic Neoplasms 5Neuroblastoma 5Leukemia, Lymphocytic, Chronic, B-Cell 5Lymphoma, Follicular 4Burkitt Lymphoma 4Wilms Tumor 3Small Cell Lung Carcinoma 3Sarcoma, Kaposi 3Sarcoma 3Rhabdoid Tumor 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Precancerous Conditions 3Ovarian Neoplasms 3Osteosarcoma 3Neuroectodermal Tumors, Primitive, Peripheral 3Myeloproliferative Disorders 3Myelodysplastic Syndromes 3Medulloblastoma 3

Interventions

Etoposide 4Cyclophosphamide 4Vincristine 3Specimen Handling 3Prednisone 3Magnetic Resonance Spectroscopy 3Doxorubicin 3Biopsy 3fludarabine phosphate 2cabozantinib 2Whole-Body Irradiation 2Watchful Waiting 2Rituximab 2Polymerase Chain Reaction 2Peripheral Blood Stem Cell Transplantation 2Nivolumab 2Light Coagulation 2Imiquimod 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Gene Expression Profiling 2Fluorouracil 2technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1prednylidene 1pembrolizumab 1fludarabine 1emvododstat 1efineptakin alfa 1deltacortene 1carmustine, poliferprosan 20 drug combination 1Vorinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × HIV Infections × Biopsy × Clear all
NCT02408861 2026-01-21

Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 1 Terminated
79 enrolled 24 charts
GastrointestinalSarcomaThoracic

Anus Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Sarcoma, Kaposi, HIV Infections

NCT02595866 2024-08-09

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

National Cancer Institute (NCI)

Phase 1 Completed
58 enrolled 17 charts
DermatologicGastrointestinalLymphoidSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular, Lung Neoplasms, Lymphoma, Non-Hodgkin, Melanoma, Neoplasm Metastasis, Neoplasms, Recurrence, Sarcoma, Kaposi, HIV Infections

NCT00686842 2018-06-06

PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma

AIDS Malignancy Consortium

Phase 1/2 Terminated
17 enrolled 7 charts
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡